NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

Thank you Beartrap for your input. One thing that bothers me is that
the response I received from AI implies that the switch from manual to
the Flaskworks methodology would obviously delay the approval and is
therefore a material event that should have been PRd.

euhhhh euhmmm huh?
As the Company has previously reported, the Flaskworks system is specially designed to carry out the key manufacturing processes for DCVax-L products on a closed basis. Flaskworks closed system as key to enabling DCVax-L production to begin taking place in Grade C suites rather than Grade B suites – and the Company views such transition to Grade C suites as central to large scale-up of production.

Other than that its not a material event